{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:15:35Z","timestamp":1785402935508,"version":"3.56.0"},"reference-count":15,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction:\u00a0Paediatric classical Hodgkin Lymphoma (cHL) can be treated successfully with modern therapeutic regimens. In the context of risk-adapted treatment strategies, accurate staging and risk stratification are crucial to improve outcomes. Although fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) detects bone marrow (BM) involvement accurately in cHL and is recommended over BM biopsies in the staging of paediatric cHL, this imaging modality is not widely available in most African countries, and BM biopsies continue to be performed.\nCase presentation:\u00a0An 8-year-old HIV-negative boy from Lesotho was referred to the Universitas Academic Hospital Paediatric Oncology Unit, South Africa, in March 2024, with a 2-year history of a progressively enlarging neck mass, fever, loss of appetite, hepatosplenomegaly, and cytopenias. Bilateral BM aspirate and trephine biopsies revealed discrepant results: The right-sided biopsy showed only reactive features, whereas the left side confirmed a diagnosis of stage 4 cHL.\nManagement and Outcome:\u00a0The child was initiated on the high-risk arm of the South African cHL treatment protocol. Owing to availability and cost constraints, a PET-CT could neither be done at diagnosis nor to evaluate his initial therapeutic response. Instead, repeat bilateral BM and CT investigations were performed to guide management as per the protocol. He completed all treatment and remains in complete remission 2 years later.\nConclusion:\u00a0Delayed referral and diagnosis of paediatric cancers remain a problem in Africa and may contribute to advanced disease at presentation. In this child, correct staging and risk stratification of cHL ensured optimal treatment selection and a favourable outcome.\nWhat this study adds:\u00a0Bilateral, rather than unilateral BM biopsies should be considered for cHL staging where PET-CT is unavailable.<\/jats:p>","DOI":"10.4102\/ajlm.v15i1.3111","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:45:13Z","timestamp":1785401113000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Should bilateral (versus unilateral) bone marrow biopsies be routine in paediatric classical Hodgkin Lymphoma where PET-CT is unavailable?"],"prefix":"10.4102","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-5460","authenticated-orcid":false,"given":"Stephanie J.","family":"Kennedy","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/009xwd568","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Free State"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1114-2242","authenticated-orcid":false,"given":"Mampoi T.","family":"Jonas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/009xwd568","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Free State"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-4061","authenticated-orcid":false,"given":"Anne-Cecilia","family":"van Marle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/009xwd568","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Free State"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-2793","authenticated-orcid":false,"given":"Jan","family":"du Plessis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/009xwd568","id-type":"ROR","asserted-by":"publisher"}],"name":"University of the Free State"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Voltin CA, Goergen H, Baues C, et al. Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: Results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann Oncol. 2018;29(9):1926\u20131931. https:\/\/doi.org\/10.1093\/annonc\/mdy250","DOI":"10.1093\/annonc\/mdy250"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Li Z, Li C, Chen B, et al. FDG-PET\/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: A systematic review and meta-analysis. J Orthop Surg. 2021;16(1):482. https:\/\/doi.org\/10.1186\/s13018-021-02521-3","DOI":"10.1186\/s13018-021-02521-3"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hines-Thomas MR, Howard SC, Hudson MM, et al. Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin\u2019s lymphoma. Haematologica. 2010;95(10):1691\u20131696. https:\/\/doi.org\/10.3324\/haematol.2010.025072","DOI":"10.3324\/haematol.2010.025072"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano classification. J Clin Oncol. 2014;32(27):3059\u20133067. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Geel J, Van Zyl A, Du Plessis J, et al. Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa. Pediatr Blood Cancer. 2024;71(1):e30712. https:\/\/doi.org\/10.1002\/pbc.30712","DOI":"10.1002\/pbc.30712"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Phillips L, Opie J. The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa. Int J Lab Hematol. 2018;40(3):276\u2013283. https:\/\/doi.org\/10.1111\/ijlh.12782","DOI":"10.1111\/ijlh.12782"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Brunning RD, Bloomfield CD, McKenna RW, Peterson L. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med. 1975;82(3):365\u2013366. https:\/\/doi.org\/10.7326\/0003-4819-82-3-365","DOI":"10.7326\/0003-4819-82-3-365"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Wang J, Weiss LM, Chang KL, et al. Diagnostic utility of bilateral bone marrow examination. Cancer. 2002;94(5):1522\u20131531. https:\/\/doi.org\/10.1002\/cncr.10364","DOI":"10.1002\/cncr.10364"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mauz-K\u00f6rholz C, Metzger ML, Kelly KM, et al. Pediatric Hodgkin Lymphoma. J Clin Oncol. 2015;33(27):2975\u20132985. https:\/\/doi.org\/10.1200\/JCO.2014.59.4853","DOI":"10.1200\/JCO.2014.59.4853"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC, Hematology ICSI. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol. 2008;30(5):349\u2013364. https:\/\/doi.org\/10.1111\/j.1751-553X.2008.01100.x","DOI":"10.1111\/j.1751-553X.2008.01100.x"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Van Marle A-C, Coetzee I, Britz W, et al. The necessity of bilateral staging bone marrow examinations for paediatric solid tumours. S Afr J Oncol. 2022;6:a242. https:\/\/doi.org\/10.4102\/sajo.v6i0.242","DOI":"10.4102\/sajo.v6i0.242"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Menon NC, Buchanan JG. Bilateral trephine bone marrow biopsies in Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma. Pathology (Phila). 1979;11(1):53\u201357. https:\/\/doi.org\/10.3109\/00313027909063538","DOI":"10.3109\/00313027909063538"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Cotache-Condor C, Kantety V, Grimm A, et al. Determinants of delayed childhood cancer care in low- and middle-income countries: A systematic review. Pediatr Blood Cancer. 2023;70(3):e30175. https:\/\/doi.org\/10.1002\/pbc.30175","DOI":"10.1002\/pbc.30175"},{"key":"ref13","unstructured":"World Health Organization. CureAll framework: WHO Global Initiative for Childhood Cancer. Increasing access, advancing quality, saving lives [homepage on the Internet]. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2021 [cited 2025 Sep 08]. Available from: https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Atun R, Bhakta N, Denburg A, et al. Sustainable care for children with cancer: A Lancet Oncology Commission. Lancet Oncol. 2020;21(4):e185\u2013e224. https:\/\/doi.org\/10.1016\/S1470-2045(20)30022-X","DOI":"10.1016\/S1470-2045(20)30022-X"}],"container-title":["African Journal of Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/ajlmonline.org\/index.php\/ajlm\/article\/view\/3111\/3589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:45:16Z","timestamp":1785401116000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajlmonline.org\/index.php\/ajlm\/article\/view\/3111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/ajlm.v15i1.3111","relation":{},"ISSN":["2225-2002","2225-2010"],"issn-type":[{"value":"2225-2002","type":"print"},{"value":"2225-2010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"a3111"}}